Protelos® significantly reduces non vertebral fracture risk in postmenopausal women with osteoporosis

The results of the TROPOS (Treatment of Peripheral Osteoporosis) study, published today in the Journal of Clinical Endocrinology and Metabolism show that strontium ranelate (Protelos®) significantly reduces the risk of all non vertebral and, in a high risk group, hip fractures over three years.

Recent Blog Post

Researchers challenge focus on rural older adults in Chris Whitty’s latest health report 

Tuesday 4th June – by Aaruthy Suthahar In a report published this week in Clinical Medicine, researchers from the Centre...

Study Reveals ZOE Personalised Diets Yield Health Improvements 

9th May 2024 – by Aaruthy Suthahar In a recent study published in the scientific journal Nature Medicine, researchers from...

New Study Reveals Epigenetic Markers for Type 2 Diabetes Complications in Identical Twins 

23rd April 2024 – by Aaruthy Suthahar A recent collaborative effort among seven international twin cohorts, including TwinsUK, has yielded...